Finance.Foundation
finance.foundation / Companies / AstraZeneca (AZN)
Company · Healthcare · Pharmaceuticals

AstraZeneca (AZN)

Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.

Legal name
AstraZeneca PLC
Ticker
AZN
Exchange
London Stock Exchange · MIC XLON
Country
United Kingdom
Sector
Healthcare
Industry
Pharmaceuticals
Market cap ≈
$230bn (approx., seed-0.6 · 2026-08-29)
Reporting currency
GBP
Founded
1999
Website
www.astrazeneca.com
LEI
PY6ZZQWO2IZFZC3IOL08 (GLEIF)
ISIN
GB0009895292 (check digit validated)
FIGI
BBG001SCNW31 (share class, OpenFIGI)

Graph connections view in graph →

lists_onLondon Stock Exchange
domiciled_inUnited Kingdom member_ofFTSE 100

Sector peers — Healthcare

Compare: AZN vs LLY · AZN vs UNH · AZN vs JNJ

Identifier crosswalk

StandardValueWhat it answers
Ticker AZN Venue-local shorthand — ambiguous across markets
MIC XLON ISO 10383 — the venue
ISIN GB0009895292 ISO 6166 — the security
LEI PY6ZZQWO2IZFZC3IOL08 ISO 17442 — the legal entity
FIGI BBG001SCNW31 OpenFIGI — instrument, share class

One entity, six naming systems. Each linked code opens its reverse-lookup page; the validator checks any code's check digit. CUSIP is shown because it is embedded in US/CA ISINs — we verify it, we do not redistribute CUSIP data.

Approximate reference values from public sources · seed-0.6 · 2026-08-29 · not real-time. See data & methodology.

# this page as data GET https://finance.foundation/api/v1/companies/astrazeneca